A Drug Enforcement Administration (DEA) hearing The Trump administration’s cannabis rescheduling proposal concluded, and the agency judge overseeing the proceeding set a deadline for the parties involved to file post-hearing briefs before the next recommendation on reform.
The multi-day hearing, which began late last month, ended Wednesday after presentations from a handful of states opposing federal cannabis reform.
DEA Chief Administrative Law Judge Derek Julius issued an order Thursday, saying that because “no closing time was granted” during the court days, participants in the process will be able to file post-trial documents, which are due Aug. 17.
Those documents can be up to 50 pages long and can include “closing arguments and arguments on any other matter raised by the court at the hearing.”
“This is a non-mandatory submission, so a named party will not be penalized for failing to file a post-hearing brief, and the absence of a submission means that there was no submission,” Julius wrote.
His order also states that participants can submit corrections to the daily transcripts of the proceedings by August 17.
“The amendments submitted by the designated parties are only proposed amendments. This panel will also examine the transcript for possible errors and indicate where amendments are needed,” wrote the judge. “The list created by the court will be compared with the list submitted by the Named Parties to create a list of final corrections. Thereafter, this court will issue an order approving the list of final corrections and include those corrections in the official copy of the transcript.”
“A fully redacted copy of the transcript of these proceedings will be made publicly available on the Agency’s website,” Julius said.
The judge said in his closing statement at the end of Wednesday’s hearing that he will work on writing his recommendation after receiving the next briefs on whether the government should move forward with broad marijuana rescheduling, but stressed that the final decision would rest with the DEA administrator.
Julius did not specify an anticipated timeline for the administrator’s recommendation of action.
At the hearing, DEA officials were tasked with defending the proposed cannabis reorganization featured testimony about the medical benefits of marijuana and its relative safety compared to other substances such as alcohol and opioids. It included appearances by a Food and Drug Administration (FDA) scientist and a doctor from New Hampshire. Medical marijuana provides relief to pain patients and can serve as an alternative to opioids.
Meanwhile, attorneys and witnesses for the parties opposing marijuana redistricting who attended the hearing focused on the alleged harms of cannabis use, as well as criticism of the recently approved changes. an analysis used to determine whether or not drugs have approved medical value.
DEA Administrator Terrance Cole only organizations and individuals opposed to marijuana reform have been invited to the hearing as a designated participant – telling followers that they do not meet the definition of “interested person” to participate because they are not “affected or prejudiced by any rule or proposed rule that may be issued.”
Participating opposition parties include Smart Approaches to Marijuana, the National Drug & Alcohol Screening Association, the Tennessee Bureau of Investigation, DUID Victim Voices, Kenneth Finn, Phillip A. Drum, and the states of Idaho, Indiana, and Nebraska.
Before the hearing began last month, marijuana reform activists rallied They held a press conference outside DEA headquarters to highlight how they feel of the process – that supporters of the reform were not invited to participate and that the proceedings were not broadcast live, despite the officials’ vow of “transparency”.
Marihuana Moments sent petitions to DEA Chief Administrative Law Judge Derek Julius and DEA Administrator Cole asking for them reverse the decision to ban the public from tuning into the cannabis hearing via live stream. A Congressmen and other journalists later joined that request.
—
Marijuana Moment’s journalism is made possible by readers like you, who value this work enough to support us monthly pledges on Patreon. If you rely on our reports to stay informed of important developments in cannabis, please help us do this becoming a permanent subscriber today.
Backing us at the $25/month level, you’ll have access to our Bill Tracker so you don’t miss any important marijuana legislation in your state.
—
Acting Attorney General Todd Blanche in April He issued an order that immediately reclassified the state’s licensed medical cannabisas well as marijuana products approved by the Food and Drug Administration (FDA) under Schedule I through Schedule III of the Controlled Substances Act (CSA).
A separate order was signed by the acting attorney general hearing marijuana III.
Preliminary hearing process on the marijuana redistricting process initiated by the Biden administration It was halted last year amid allegations of improper communications and witness selection.
the current The marijuana redistricting process is being challenged in several ways which have been upheld by a federal Court of Appeals. those pieces of State attorneys general have filed lawsuits against cannabis reform, Opponents of marijuana legalization and a a cannabis-based biopharmaceutical corporation.
Meanwhile, the reorganization of state-licensed medical cannabis is already having a major impact.
The Congressional Research Service published a report on the current rescheduling of cannabis Certified patients with medical marijuana from state licensed dispensaries are now eligible for Class III. “The order appears to allow end users to use marijuana medically without a CSA prescription,” he says.
The Bureau of Alcohol, Tobacco, Firearms and Explosives (ATF) has published a Draft update to a gun purchase form to recognize the legal status of medical marijuana in the reprogramming. The revised section of the question states that only the “recreational use or possession of marijuana” is federally prohibited, omitting the prior form’s mention of medical cannabis.
The US Treasury and Internal Revenue Service (IRS) said they plan to issued new tax guidelines for the marijuana industry after reprogramming. The reform will benefit state-licensed marijuana businesses by allowing them to take federal tax deductions that are currently prohibited under IRS Code Section III, known as Section 280E.
Even the DEA, which has long opposed cannabis legalization and accused the Biden administration of stalling the initiative in the reorganization process, has done so. It launched a registration process for legal marijuana businesses in the state to take advantage of the federal benefits that come with the reform.
The Department of Transport, on the other hand, issued guidelines stating this use Legal medical cannabis in the state is still no excuse for truck drivers to test positive for drugspilots and other safety-sensitive personnel.
The The War Department released a memo making it clear that military service members were using marijuana and civilian employees of the department remain prohibited, even in the federal rescheduling of cannabis.
A congressional committee recently Federal officials voted to block further steps to reschedule cannabishowever lawmakers from both parties told Marihuana Moment they don’t think that provision will be enacted become law
Read the DEA’s post-trial hearing the order below: